e-Article
The Novel SYK/JAK Inhibitor Cerdulatinib Demonstrates Good Tolerability and Clinical Response in a Phase 2a Study in Relapsed/Refractory Peripheral T-Cell Lymphoma and Cutaneous T-Cell Lymphoma
Document Type
Journal
Author
Horwitz, Steven M.; Feldman, Tatyana A.; Hess, Brian T.; Khodadoust, Michael S.; Kim, Youn H.; Munoz, Javier; Patel, Manish R.; Phillips, Tycel J.; Smith, Stephen D.; Smith, Sonali M.; Wilcox, Ryan A.; Steele, Andrew; Pandey, Anjali; Birrell, Matt R.; Leeds, Janet M.; Conley, Pamela B.; Michelson, Glenn; Coffey, Gregory P.; Curnutte, John T.; Hamlin, Paul A.
Source
Subject
Language
English
ISSN
15280020